Pallas Capital Advisors LLC Has $11.30 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Pallas Capital Advisors LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,154 shares of the healthcare conglomerate’s stock after selling 596 shares during the period. Pallas Capital Advisors LLC’s holdings in UnitedHealth Group were worth $11,302,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Woodmont Investment Counsel LLC raised its position in shares of UnitedHealth Group by 7.2% during the 1st quarter. Woodmont Investment Counsel LLC now owns 20,928 shares of the healthcare conglomerate’s stock valued at $10,353,000 after acquiring an additional 1,404 shares during the last quarter. Applied Capital LLC FL boosted its holdings in UnitedHealth Group by 6.2% during the first quarter. Applied Capital LLC FL now owns 4,463 shares of the healthcare conglomerate’s stock worth $2,208,000 after buying an additional 260 shares during the last quarter. Dash Acquisitions Inc. increased its stake in shares of UnitedHealth Group by 4.3% in the 1st quarter. Dash Acquisitions Inc. now owns 650 shares of the healthcare conglomerate’s stock valued at $311,000 after acquiring an additional 27 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its stake in UnitedHealth Group by 13.8% during the 1st quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 119,665 shares of the healthcare conglomerate’s stock worth $59,198,000 after acquiring an additional 14,489 shares during the last quarter. Finally, Financial Security Advisor Inc. increased its stake in UnitedHealth Group by 8.8% in the first quarter. Financial Security Advisor Inc. now owns 1,873 shares of the healthcare conglomerate’s stock valued at $926,000 after purchasing an additional 152 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.2 %

UnitedHealth Group stock opened at $565.46 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The stock has a 50-day simple moving average of $583.25 and a 200 day simple moving average of $539.45. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a market capitalization of $522.16 billion, a P/E ratio of 36.84, a PEG ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the business posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

A number of research firms recently commented on UNH. UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Bank of America dropped their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.